GoldenGolden
The Column Group

The Column Group

A venture capital firm in California that focuses on developing biotechnology companies.

The Column Group is a venture capital firm in California that focuses on developing biotechnology companies. Founded 2006 in San Francisco, California, United States by Adriana Tajonar and Peter Svennilson, it invests in early stage ventures, late stage ventures, private equity, seed, series B, series A, series C, and series E rounds. Its portfolio companies include Circle Pharma, Nurix, A2 Biotherapeutics, Plexium, and Tenaya Therapeutics. As of March 2020, The Column Group has made 67 investments. Their most recent investment was on March 17, 2020, when Circle Pharma raised $45M. The Column Group has had 13 exits, the most notable of which include PTC Therapeutics, Peloton Therapeutics, and NGM Biopharmaceuticals. The Column Group has raised three funds, their latest being Column Group IV.

Timeline

2006
Founded

Funded Companies

Company
Description
Industry
Website
Location
Kallyope

Kallyope is a New York City, New York based biotechnology company founded in 2015 developing therapeutics to improve human health by better understanding the gut-brain relationship.

Biotechnology company developing cell permeable macrocyclic peptide therapeutics using an automated chemistry synthesis.

Gritstone Oncology is a Emeryville, California-based biotechnology company developing neoantigen-specific cancer immunotherapies.

A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics

Casma Therapeutics is a company that has a research community and uses its understanding of research to develop novel therapeutics to capture disease causing targets.

Exonics Therapeutics was a Dallas-based biotechnology company developing gene editing therapies.

Hexagon Bio is a technology company focused in oncology.

A company developing protein homeostasis therapies for oncology, immunology, and inflammation cases

A biotechnology company developing drugs for the treatment of metabolic diseases, cancer and inflammation

A company that develops therapeutics for the treatment of cancer

ORIC Pharmaceuticals is a South San Francisco, California-based company.

Surrozen is a South San Francisco, California-based company.

REVOLUTION Medicines is a Redwood City, California-based company.

Escient Pharmaceuticals is a San Diego-based company.

A company developing cancer therapeutics

Accent Therapeutics is a Lexington, Massachusetts-based company.

Tenaya Therapeutics is a San Francisco-based company.

FLX Bio is a South San Francisco, California-based company.

21 Results
Results per page:
Page 1 of 1

Associated investment funds

Investment Fund
Total offering (USD)
Total sold (USD)
Location
Date signed
350,000,000
65,500,000
March 10, 2010
500,000,000
February 29, 2016
500,000,000
February 29, 2016
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

James Evangelista

Chief Financial Officer

Carla Daniel

Vice President, Head of Talent

Larry Lasky

Partner

Michael S. Brown

Science Partner

Sue Murakami

Manager of Administration

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

A2 Biotherapeutics

Circle Pharma

Nurix

Plexium

News

Title
Author
Date
Publisher
Description
Kate Goodwin
April 21, 2021
BioSpace
Investment funds continue springing up into life sciences companies across the globe. Here's where the money's being planted this week.
Kate Goodwin
April 20, 2021
BioSpace
Science-driven VC firm The Column Group set up its debut crossover fund with an oversubscribed $824 million to start.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.